640 related articles for article (PubMed ID: 25615431)
21. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice.
Jaworska J; Dancik Y; Kern P; Gerberick F; Natsch A
J Appl Toxicol; 2013 Nov; 33(11):1353-64. PubMed ID: 23670904
[TBL] [Abstract][Full Text] [Related]
22. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
[TBL] [Abstract][Full Text] [Related]
23. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.
Wilson VS; Keshava N; Hester S; Segal D; Chiu W; Thompson CM; Euling SY
Toxicol Appl Pharmacol; 2013 Sep; 271(3):299-308. PubMed ID: 21295051
[TBL] [Abstract][Full Text] [Related]
24. Use of genomic data in risk assessment case study: I. Evaluation of the dibutyl phthalate male reproductive development toxicity data set.
Makris SL; Euling SY; Gray LE; Benson R; Foster P
Toxicol Appl Pharmacol; 2013 Sep; 271(3):336-48. PubMed ID: 20849870
[TBL] [Abstract][Full Text] [Related]
25. Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of 'Omics' Data from Human Cell Cultures.
Grafström RC; Nymark P; Hongisto V; Spjuth O; Ceder R; Willighagen E; Hardy B; Kaski S; Kohonen P
Altern Lab Anim; 2015 Nov; 43(5):325-32. PubMed ID: 26551289
[TBL] [Abstract][Full Text] [Related]
26. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
27. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
Meek ME; Lipscomb JC
Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
[TBL] [Abstract][Full Text] [Related]
28. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
29. The SEURAT-1 approach towards animal free human safety assessment.
Gocht T; Berggren E; Ahr HJ; Cotgreave I; Cronin MT; Daston G; Hardy B; Heinzle E; Hescheler J; Knight DJ; Mahony C; Peschanski M; Schwarz M; Thomas RS; Verfaillie C; White A; Whelan M
ALTEX; 2015; 32(1):9-24. PubMed ID: 25372315
[TBL] [Abstract][Full Text] [Related]
30. Toxicity testing in the 21st century: progress in the past decade and future perspectives.
Krewski D; Andersen ME; Tyshenko MG; Krishnan K; Hartung T; Boekelheide K; Wambaugh JF; Jones D; Whelan M; Thomas R; Yauk C; Barton-Maclaren T; Cote I
Arch Toxicol; 2020 Jan; 94(1):1-58. PubMed ID: 31848664
[TBL] [Abstract][Full Text] [Related]
31. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
[TBL] [Abstract][Full Text] [Related]
32. [Non-animal toxicology in the safety testing of chemicals].
Heinonen T; Tähti H
Duodecim; 2013; 129(16):1686-94. PubMed ID: 24069638
[TBL] [Abstract][Full Text] [Related]
33. Building on a solid foundation: SAR and QSAR as a fundamental strategy to reduce animal testing.
Sullivan KM; Manuppello JR; Willett CE
SAR QSAR Environ Res; 2014; 25(5):357-65. PubMed ID: 24773450
[TBL] [Abstract][Full Text] [Related]
34. ECVAM and new technologies for toxicity testing.
Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
[TBL] [Abstract][Full Text] [Related]
35. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
[TBL] [Abstract][Full Text] [Related]
36. Use and validation of HT/HC assays to support 21st century toxicity evaluations.
Patlewicz G; Simon T; Goyak K; Phillips RD; Rowlands JC; Seidel SD; Becker RA
Regul Toxicol Pharmacol; 2013 Mar; 65(2):259-68. PubMed ID: 23291301
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database.
Hu B; Gifford E; Wang H; Bailey W; Johnson T
Chem Res Toxicol; 2015 Nov; 28(11):2210-23. PubMed ID: 26505644
[TBL] [Abstract][Full Text] [Related]
38. Are adverse outcome pathways here to stay?
Garcia-Reyero N
Environ Sci Technol; 2015 Jan; 49(1):3-9. PubMed ID: 25469516
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the proposed EU regulation concerning biocide products and its opportunities for alternative approaches and a toxicology for the 21st century.
Ferrario D; Rabbit RR
ALTEX; 2012; 29(2):157-72. PubMed ID: 22562488
[TBL] [Abstract][Full Text] [Related]
40. Pathway Based Toxicology and Fit-for-Purpose Assays.
Clewell RA; McMullen PD; Adeleye Y; Carmichael PL; Andersen ME
Adv Exp Med Biol; 2016; 856():205-230. PubMed ID: 27671724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
